Augmedix, Inc. provided earnings guidance for the second quarter ended June 30, 2021. Preliminary second quarter 2021 total revenue is expected to be $5.2 million, an increase of 8.0% compared to the first quarter of 2021 and up 39% compared to the second quarter of 2020. Preliminary second quarter 2021 dollar-based net revenue retention was 129% for Health Enterprise customers compared to 113% in the first quarter of 2021.